nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—Beclomethasone—psoriasis	0.181	0.248	CbGbCtD
Argatroban—CYP3A5—Mycophenolate mofetil—psoriasis	0.0719	0.0987	CbGbCtD
Argatroban—CYP3A4—Calcitriol—psoriasis	0.0627	0.0862	CbGbCtD
Argatroban—CYP3A5—Hydrocortisone—psoriasis	0.0577	0.0792	CbGbCtD
Argatroban—CYP3A5—Cyclosporine—psoriasis	0.0545	0.0748	CbGbCtD
Argatroban—CYP3A4—Methoxsalen—psoriasis	0.0488	0.067	CbGbCtD
Argatroban—CYP3A5—Dexamethasone—psoriasis	0.0359	0.0493	CbGbCtD
Argatroban—CYP3A4—Cholecalciferol—psoriasis	0.0323	0.0444	CbGbCtD
Argatroban—CYP3A4—Mycophenolate mofetil—psoriasis	0.028	0.0385	CbGbCtD
Argatroban—CYP3A4—Triamcinolone—psoriasis	0.028	0.0385	CbGbCtD
Argatroban—CYP3A4—Betamethasone—psoriasis	0.024	0.033	CbGbCtD
Argatroban—CYP3A4—Prednisolone—psoriasis	0.0237	0.0326	CbGbCtD
Argatroban—CYP3A4—Hydrocortisone—psoriasis	0.0225	0.0309	CbGbCtD
Argatroban—CYP3A4—Prednisone—psoriasis	0.0224	0.0308	CbGbCtD
Argatroban—CYP3A4—Cyclosporine—psoriasis	0.0212	0.0292	CbGbCtD
Argatroban—CYP3A4—Dexamethasone—psoriasis	0.014	0.0192	CbGbCtD
Argatroban—F2—vertebral column—psoriasis	0.00478	0.692	CbGeAlD
Argatroban—F2—endothelium—psoriasis	0.00213	0.308	CbGeAlD
Argatroban—Bradycardia—Prednisolone—psoriasis	0.000414	0.00158	CcSEcCtD
Argatroban—Dyspepsia—Hydroxyurea—psoriasis	0.000413	0.00157	CcSEcCtD
Argatroban—Thrombophlebitis—Methotrexate—psoriasis	0.000413	0.00157	CcSEcCtD
Argatroban—Acute coronary syndrome—Triamcinolone—psoriasis	0.000411	0.00156	CcSEcCtD
Argatroban—Chest pain—Mycophenolic acid—psoriasis	0.00041	0.00156	CcSEcCtD
Argatroban—Haemoglobin—Prednisolone—psoriasis	0.000409	0.00156	CcSEcCtD
Argatroban—Diarrhoea—Acitretin—psoriasis	0.000409	0.00155	CcSEcCtD
Argatroban—Myocardial infarction—Triamcinolone—psoriasis	0.000409	0.00155	CcSEcCtD
Argatroban—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000408	0.00155	CcSEcCtD
Argatroban—Haemorrhage—Prednisolone—psoriasis	0.000407	0.00155	CcSEcCtD
Argatroban—Cardiac arrest—Prednisone—psoriasis	0.000406	0.00155	CcSEcCtD
Argatroban—Angiopathy—Cyclosporine—psoriasis	0.000406	0.00154	CcSEcCtD
Argatroban—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000405	0.00154	CcSEcCtD
Argatroban—Bradycardia—Hydrocortisone—psoriasis	0.000405	0.00154	CcSEcCtD
Argatroban—Pain—Hydroxyurea—psoriasis	0.000401	0.00153	CcSEcCtD
Argatroban—Constipation—Hydroxyurea—psoriasis	0.000401	0.00153	CcSEcCtD
Argatroban—Haemoglobin—Hydrocortisone—psoriasis	0.000399	0.00152	CcSEcCtD
Argatroban—Nausea—Calcitriol—psoriasis	0.000399	0.00152	CcSEcCtD
Argatroban—Haemorrhage—Hydrocortisone—psoriasis	0.000397	0.00151	CcSEcCtD
Argatroban—Confusional state—Mycophenolic acid—psoriasis	0.000396	0.00151	CcSEcCtD
Argatroban—Angiopathy—Mycophenolate mofetil—psoriasis	0.000396	0.00151	CcSEcCtD
Argatroban—Dizziness—Acitretin—psoriasis	0.000395	0.0015	CcSEcCtD
Argatroban—Dizziness—Fluocinolone Acetonide—psoriasis	0.000394	0.0015	CcSEcCtD
Argatroban—Infection—Mycophenolic acid—psoriasis	0.00039	0.00148	CcSEcCtD
Argatroban—Renal failure acute—Methotrexate—psoriasis	0.000387	0.00147	CcSEcCtD
Argatroban—Feeling abnormal—Hydroxyurea—psoriasis	0.000386	0.00147	CcSEcCtD
Argatroban—Tachycardia—Mycophenolic acid—psoriasis	0.000383	0.00146	CcSEcCtD
Argatroban—Bradycardia—Triamcinolone—psoriasis	0.000381	0.00145	CcSEcCtD
Argatroban—Vomiting—Acitretin—psoriasis	0.00038	0.00144	CcSEcCtD
Argatroban—Vomiting—Fluocinolone Acetonide—psoriasis	0.000379	0.00144	CcSEcCtD
Argatroban—Rash—Acitretin—psoriasis	0.000377	0.00143	CcSEcCtD
Argatroban—Dermatitis—Acitretin—psoriasis	0.000376	0.00143	CcSEcCtD
Argatroban—Haemoglobin—Triamcinolone—psoriasis	0.000376	0.00143	CcSEcCtD
Argatroban—Rash—Fluocinolone Acetonide—psoriasis	0.000376	0.00143	CcSEcCtD
Argatroban—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000375	0.00143	CcSEcCtD
Argatroban—Haemorrhage—Triamcinolone—psoriasis	0.000374	0.00142	CcSEcCtD
Argatroban—Headache—Acitretin—psoriasis	0.000374	0.00142	CcSEcCtD
Argatroban—Headache—Fluocinolone Acetonide—psoriasis	0.000373	0.00142	CcSEcCtD
Argatroban—Acute coronary syndrome—Betamethasone—psoriasis	0.000373	0.00142	CcSEcCtD
Argatroban—Acute coronary syndrome—Dexamethasone—psoriasis	0.000373	0.00142	CcSEcCtD
Argatroban—Myocardial infarction—Dexamethasone—psoriasis	0.000371	0.00141	CcSEcCtD
Argatroban—Myocardial infarction—Betamethasone—psoriasis	0.000371	0.00141	CcSEcCtD
Argatroban—Body temperature increased—Hydroxyurea—psoriasis	0.000371	0.00141	CcSEcCtD
Argatroban—Back pain—Mycophenolate mofetil—psoriasis	0.000367	0.0014	CcSEcCtD
Argatroban—Hypotension—Mycophenolic acid—psoriasis	0.000367	0.0014	CcSEcCtD
Argatroban—Cerebrovascular accident—Methotrexate—psoriasis	0.000365	0.00139	CcSEcCtD
Argatroban—Nausea—Acitretin—psoriasis	0.000355	0.00135	CcSEcCtD
Argatroban—Nausea—Fluocinolone Acetonide—psoriasis	0.000354	0.00135	CcSEcCtD
Argatroban—Dyspnoea—Mycophenolic acid—psoriasis	0.00035	0.00133	CcSEcCtD
Argatroban—Dyspepsia—Mycophenolic acid—psoriasis	0.000346	0.00132	CcSEcCtD
Argatroban—Bradycardia—Dexamethasone—psoriasis	0.000346	0.00132	CcSEcCtD
Argatroban—Bradycardia—Betamethasone—psoriasis	0.000346	0.00132	CcSEcCtD
Argatroban—Hypersensitivity—Hydroxyurea—psoriasis	0.000345	0.00131	CcSEcCtD
Argatroban—Haemoglobin—Betamethasone—psoriasis	0.000341	0.0013	CcSEcCtD
Argatroban—Haemoglobin—Dexamethasone—psoriasis	0.000341	0.0013	CcSEcCtD
Argatroban—Cough—Cyclosporine—psoriasis	0.00034	0.00129	CcSEcCtD
Argatroban—Haemorrhage—Betamethasone—psoriasis	0.00034	0.00129	CcSEcCtD
Argatroban—Haemorrhage—Dexamethasone—psoriasis	0.00034	0.00129	CcSEcCtD
Argatroban—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000339	0.00129	CcSEcCtD
Argatroban—Pain—Mycophenolic acid—psoriasis	0.000336	0.00128	CcSEcCtD
Argatroban—Constipation—Mycophenolic acid—psoriasis	0.000336	0.00128	CcSEcCtD
Argatroban—Chest pain—Cyclosporine—psoriasis	0.000331	0.00126	CcSEcCtD
Argatroban—Cough—Mycophenolate mofetil—psoriasis	0.000331	0.00126	CcSEcCtD
Argatroban—Acute coronary syndrome—Prednisone—psoriasis	0.000325	0.00124	CcSEcCtD
Argatroban—Feeling abnormal—Mycophenolic acid—psoriasis	0.000324	0.00123	CcSEcCtD
Argatroban—Chest pain—Mycophenolate mofetil—psoriasis	0.000323	0.00123	CcSEcCtD
Argatroban—Myocardial infarction—Prednisone—psoriasis	0.000323	0.00123	CcSEcCtD
Argatroban—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000321	0.00122	CcSEcCtD
Argatroban—Diarrhoea—Hydroxyurea—psoriasis	0.000321	0.00122	CcSEcCtD
Argatroban—Confusional state—Cyclosporine—psoriasis	0.00032	0.00122	CcSEcCtD
Argatroban—Infection—Cyclosporine—psoriasis	0.000316	0.0012	CcSEcCtD
Argatroban—Back pain—Triamcinolone—psoriasis	0.000315	0.0012	CcSEcCtD
Argatroban—Confusional state—Mycophenolate mofetil—psoriasis	0.000313	0.00119	CcSEcCtD
Argatroban—Abdominal pain—Mycophenolic acid—psoriasis	0.00031	0.00118	CcSEcCtD
Argatroban—Body temperature increased—Mycophenolic acid—psoriasis	0.00031	0.00118	CcSEcCtD
Argatroban—Dizziness—Hydroxyurea—psoriasis	0.00031	0.00118	CcSEcCtD
Argatroban—Angiopathy—Dexamethasone—psoriasis	0.000308	0.00117	CcSEcCtD
Argatroban—Angiopathy—Betamethasone—psoriasis	0.000308	0.00117	CcSEcCtD
Argatroban—Infection—Mycophenolate mofetil—psoriasis	0.000308	0.00117	CcSEcCtD
Argatroban—Tachycardia—Mycophenolate mofetil—psoriasis	0.000303	0.00115	CcSEcCtD
Argatroban—Bradycardia—Prednisone—psoriasis	0.000301	0.00115	CcSEcCtD
Argatroban—Vomiting—Hydroxyurea—psoriasis	0.000298	0.00113	CcSEcCtD
Argatroban—Haemoglobin—Prednisone—psoriasis	0.000297	0.00113	CcSEcCtD
Argatroban—Haemorrhage—Prednisone—psoriasis	0.000296	0.00112	CcSEcCtD
Argatroban—Rash—Hydroxyurea—psoriasis	0.000296	0.00112	CcSEcCtD
Argatroban—Dermatitis—Hydroxyurea—psoriasis	0.000295	0.00112	CcSEcCtD
Argatroban—Headache—Hydroxyurea—psoriasis	0.000294	0.00112	CcSEcCtD
Argatroban—Hypotension—Mycophenolate mofetil—psoriasis	0.00029	0.0011	CcSEcCtD
Argatroban—Cough—Triamcinolone—psoriasis	0.000284	0.00108	CcSEcCtD
Argatroban—Dyspnoea—Cyclosporine—psoriasis	0.000283	0.00108	CcSEcCtD
Argatroban—Tachycardia—Prednisolone—psoriasis	0.000282	0.00107	CcSEcCtD
Argatroban—Infection—Hydrocortisone—psoriasis	0.000281	0.00107	CcSEcCtD
Argatroban—Dyspepsia—Cyclosporine—psoriasis	0.00028	0.00106	CcSEcCtD
Argatroban—Nausea—Hydroxyurea—psoriasis	0.000279	0.00106	CcSEcCtD
Argatroban—Pneumonia—Methotrexate—psoriasis	0.000277	0.00105	CcSEcCtD
Argatroban—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000276	0.00105	CcSEcCtD
Argatroban—Tachycardia—Hydrocortisone—psoriasis	0.000276	0.00105	CcSEcCtD
Argatroban—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000274	0.00104	CcSEcCtD
Argatroban—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000273	0.00104	CcSEcCtD
Argatroban—Pain—Cyclosporine—psoriasis	0.000272	0.00103	CcSEcCtD
Argatroban—Constipation—Cyclosporine—psoriasis	0.000272	0.00103	CcSEcCtD
Argatroban—Diarrhoea—Mycophenolic acid—psoriasis	0.000269	0.00102	CcSEcCtD
Argatroban—Angiopathy—Prednisone—psoriasis	0.000268	0.00102	CcSEcCtD
Argatroban—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000268	0.00102	CcSEcCtD
Argatroban—Pain—Mycophenolate mofetil—psoriasis	0.000265	0.00101	CcSEcCtD
Argatroban—Constipation—Mycophenolate mofetil—psoriasis	0.000265	0.00101	CcSEcCtD
Argatroban—Infection—Triamcinolone—psoriasis	0.000264	0.001	CcSEcCtD
Argatroban—Hypotension—Hydrocortisone—psoriasis	0.000264	0.001	CcSEcCtD
Argatroban—Haematuria—Methotrexate—psoriasis	0.000263	0.000999	CcSEcCtD
Argatroban—Feeling abnormal—Cyclosporine—psoriasis	0.000262	0.000996	CcSEcCtD
Argatroban—Gastrointestinal pain—Cyclosporine—psoriasis	0.00026	0.000988	CcSEcCtD
Argatroban—Dizziness—Mycophenolic acid—psoriasis	0.00026	0.000988	CcSEcCtD
Argatroban—Tachycardia—Triamcinolone—psoriasis	0.00026	0.000987	CcSEcCtD
Argatroban—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000255	0.000972	CcSEcCtD
Argatroban—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000253	0.000964	CcSEcCtD
Argatroban—Body temperature increased—Cyclosporine—psoriasis	0.000251	0.000955	CcSEcCtD
Argatroban—Abdominal pain—Cyclosporine—psoriasis	0.000251	0.000955	CcSEcCtD
Argatroban—Vomiting—Mycophenolic acid—psoriasis	0.00025	0.00095	CcSEcCtD
Argatroban—Dyspepsia—Hydrocortisone—psoriasis	0.000249	0.000946	CcSEcCtD
Argatroban—Haemoglobin—Methotrexate—psoriasis	0.000248	0.000945	CcSEcCtD
Argatroban—Rash—Mycophenolic acid—psoriasis	0.000248	0.000942	CcSEcCtD
Argatroban—Dermatitis—Mycophenolic acid—psoriasis	0.000247	0.000941	CcSEcCtD
Argatroban—Pain—Prednisolone—psoriasis	0.000247	0.000941	CcSEcCtD
Argatroban—Haemorrhage—Methotrexate—psoriasis	0.000247	0.00094	CcSEcCtD
Argatroban—Headache—Mycophenolic acid—psoriasis	0.000246	0.000936	CcSEcCtD
Argatroban—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000245	0.000932	CcSEcCtD
Argatroban—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000245	0.000932	CcSEcCtD
Argatroban—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000244	0.000927	CcSEcCtD
Argatroban—Pain—Hydrocortisone—psoriasis	0.000241	0.000919	CcSEcCtD
Argatroban—Infection—Dexamethasone—psoriasis	0.00024	0.000912	CcSEcCtD
Argatroban—Infection—Betamethasone—psoriasis	0.00024	0.000912	CcSEcCtD
Argatroban—Feeling abnormal—Prednisolone—psoriasis	0.000238	0.000906	CcSEcCtD
Argatroban—Dyspnoea—Triamcinolone—psoriasis	0.000237	0.000902	CcSEcCtD
Argatroban—Tachycardia—Dexamethasone—psoriasis	0.000235	0.000896	CcSEcCtD
Argatroban—Tachycardia—Betamethasone—psoriasis	0.000235	0.000896	CcSEcCtD
Argatroban—Hypersensitivity—Cyclosporine—psoriasis	0.000234	0.00089	CcSEcCtD
Argatroban—Dyspepsia—Triamcinolone—psoriasis	0.000234	0.00089	CcSEcCtD
Argatroban—Nausea—Mycophenolic acid—psoriasis	0.000233	0.000887	CcSEcCtD
Argatroban—Feeling abnormal—Hydrocortisone—psoriasis	0.000233	0.000885	CcSEcCtD
Argatroban—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000231	0.000878	CcSEcCtD
Argatroban—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000228	0.000869	CcSEcCtD
Argatroban—Pain—Triamcinolone—psoriasis	0.000227	0.000865	CcSEcCtD
Argatroban—Hypotension—Betamethasone—psoriasis	0.000225	0.000858	CcSEcCtD
Argatroban—Hypotension—Dexamethasone—psoriasis	0.000225	0.000858	CcSEcCtD
Argatroban—Angiopathy—Methotrexate—psoriasis	0.000224	0.000853	CcSEcCtD
Argatroban—Abdominal pain—Hydrocortisone—psoriasis	0.000223	0.000849	CcSEcCtD
Argatroban—Body temperature increased—Hydrocortisone—psoriasis	0.000223	0.000849	CcSEcCtD
Argatroban—Feeling abnormal—Triamcinolone—psoriasis	0.000219	0.000833	CcSEcCtD
Argatroban—Diarrhoea—Cyclosporine—psoriasis	0.000217	0.000827	CcSEcCtD
Argatroban—Hypersensitivity—Prednisolone—psoriasis	0.000213	0.00081	CcSEcCtD
Argatroban—Dyspepsia—Betamethasone—psoriasis	0.000212	0.000808	CcSEcCtD
Argatroban—Dyspepsia—Dexamethasone—psoriasis	0.000212	0.000808	CcSEcCtD
Argatroban—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000212	0.000807	CcSEcCtD
Argatroban—Body temperature increased—Triamcinolone—psoriasis	0.00021	0.0008	CcSEcCtD
Argatroban—Dizziness—Cyclosporine—psoriasis	0.00021	0.000799	CcSEcCtD
Argatroban—Infection—Prednisone—psoriasis	0.000209	0.000794	CcSEcCtD
Argatroban—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000208	0.000792	CcSEcCtD
Argatroban—Gastrointestinal disorder—Betamethasone—psoriasis	0.000208	0.000792	CcSEcCtD
Argatroban—Back pain—Methotrexate—psoriasis	0.000208	0.000792	CcSEcCtD
Argatroban—Hypersensitivity—Hydrocortisone—psoriasis	0.000208	0.000791	CcSEcCtD
Argatroban—Pain—Dexamethasone—psoriasis	0.000206	0.000785	CcSEcCtD
Argatroban—Pain—Betamethasone—psoriasis	0.000206	0.000785	CcSEcCtD
Argatroban—Tachycardia—Prednisone—psoriasis	0.000205	0.00078	CcSEcCtD
Argatroban—Dizziness—Mycophenolate mofetil—psoriasis	0.000205	0.00078	CcSEcCtD
Argatroban—Vomiting—Cyclosporine—psoriasis	0.000202	0.000768	CcSEcCtD
Argatroban—Rash—Cyclosporine—psoriasis	0.0002	0.000762	CcSEcCtD
Argatroban—Dermatitis—Cyclosporine—psoriasis	0.0002	0.000761	CcSEcCtD
Argatroban—Headache—Cyclosporine—psoriasis	0.000199	0.000757	CcSEcCtD
Argatroban—Feeling abnormal—Dexamethasone—psoriasis	0.000199	0.000756	CcSEcCtD
Argatroban—Feeling abnormal—Betamethasone—psoriasis	0.000199	0.000756	CcSEcCtD
Argatroban—Gastrointestinal pain—Dexamethasone—psoriasis	0.000197	0.00075	CcSEcCtD
Argatroban—Gastrointestinal pain—Betamethasone—psoriasis	0.000197	0.00075	CcSEcCtD
Argatroban—Vomiting—Mycophenolate mofetil—psoriasis	0.000197	0.00075	CcSEcCtD
Argatroban—Hypersensitivity—Triamcinolone—psoriasis	0.000196	0.000745	CcSEcCtD
Argatroban—Rash—Mycophenolate mofetil—psoriasis	0.000195	0.000743	CcSEcCtD
Argatroban—Dermatitis—Mycophenolate mofetil—psoriasis	0.000195	0.000743	CcSEcCtD
Argatroban—Headache—Mycophenolate mofetil—psoriasis	0.000194	0.000739	CcSEcCtD
Argatroban—Diarrhoea—Hydrocortisone—psoriasis	0.000193	0.000735	CcSEcCtD
Argatroban—Dizziness—Prednisolone—psoriasis	0.000191	0.000727	CcSEcCtD
Argatroban—Abdominal pain—Betamethasone—psoriasis	0.000191	0.000725	CcSEcCtD
Argatroban—Body temperature increased—Betamethasone—psoriasis	0.000191	0.000725	CcSEcCtD
Argatroban—Abdominal pain—Dexamethasone—psoriasis	0.000191	0.000725	CcSEcCtD
Argatroban—Body temperature increased—Dexamethasone—psoriasis	0.000191	0.000725	CcSEcCtD
Argatroban—Nausea—Cyclosporine—psoriasis	0.000189	0.000718	CcSEcCtD
Argatroban—Cough—Methotrexate—psoriasis	0.000188	0.000714	CcSEcCtD
Argatroban—Dizziness—Hydrocortisone—psoriasis	0.000187	0.00071	CcSEcCtD
Argatroban—Dyspepsia—Prednisone—psoriasis	0.000185	0.000704	CcSEcCtD
Argatroban—Nausea—Mycophenolate mofetil—psoriasis	0.000184	0.0007	CcSEcCtD
Argatroban—Chest pain—Methotrexate—psoriasis	0.000183	0.000697	CcSEcCtD
Argatroban—Rash—Prednisolone—psoriasis	0.000182	0.000693	CcSEcCtD
Argatroban—Dermatitis—Prednisolone—psoriasis	0.000182	0.000693	CcSEcCtD
Argatroban—Headache—Prednisolone—psoriasis	0.000181	0.000689	CcSEcCtD
Argatroban—Constipation—Prednisone—psoriasis	0.00018	0.000683	CcSEcCtD
Argatroban—Vomiting—Hydrocortisone—psoriasis	0.00018	0.000683	CcSEcCtD
Argatroban—Rash—Hydrocortisone—psoriasis	0.000178	0.000677	CcSEcCtD
Argatroban—Dermatitis—Hydrocortisone—psoriasis	0.000178	0.000677	CcSEcCtD
Argatroban—Confusional state—Methotrexate—psoriasis	0.000177	0.000673	CcSEcCtD
Argatroban—Headache—Hydrocortisone—psoriasis	0.000177	0.000673	CcSEcCtD
Argatroban—Dizziness—Triamcinolone—psoriasis	0.000176	0.000669	CcSEcCtD
Argatroban—Infection—Methotrexate—psoriasis	0.000174	0.000664	CcSEcCtD
Argatroban—Feeling abnormal—Prednisone—psoriasis	0.000173	0.000659	CcSEcCtD
Argatroban—Gastrointestinal pain—Prednisone—psoriasis	0.000172	0.000654	CcSEcCtD
Argatroban—Nausea—Prednisolone—psoriasis	0.000172	0.000653	CcSEcCtD
Argatroban—Vomiting—Triamcinolone—psoriasis	0.000169	0.000643	CcSEcCtD
Argatroban—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000168	0.0859	CbGpPWpGaD
Argatroban—Nausea—Hydrocortisone—psoriasis	0.000168	0.000638	CcSEcCtD
Argatroban—Rash—Triamcinolone—psoriasis	0.000168	0.000638	CcSEcCtD
Argatroban—Dermatitis—Triamcinolone—psoriasis	0.000167	0.000637	CcSEcCtD
Argatroban—Headache—Triamcinolone—psoriasis	0.000167	0.000634	CcSEcCtD
Argatroban—Abdominal pain—Prednisone—psoriasis	0.000166	0.000632	CcSEcCtD
Argatroban—Body temperature increased—Prednisone—psoriasis	0.000166	0.000632	CcSEcCtD
Argatroban—Diarrhoea—Betamethasone—psoriasis	0.000165	0.000628	CcSEcCtD
Argatroban—Diarrhoea—Dexamethasone—psoriasis	0.000165	0.000628	CcSEcCtD
Argatroban—Hypotension—Methotrexate—psoriasis	0.000164	0.000624	CcSEcCtD
Argatroban—Dizziness—Betamethasone—psoriasis	0.00016	0.000607	CcSEcCtD
Argatroban—Dizziness—Dexamethasone—psoriasis	0.00016	0.000607	CcSEcCtD
Argatroban—Nausea—Triamcinolone—psoriasis	0.000158	0.000601	CcSEcCtD
Argatroban—Dyspnoea—Methotrexate—psoriasis	0.000157	0.000595	CcSEcCtD
Argatroban—Hypersensitivity—Prednisone—psoriasis	0.000155	0.000589	CcSEcCtD
Argatroban—Dyspepsia—Methotrexate—psoriasis	0.000155	0.000588	CcSEcCtD
Argatroban—Vomiting—Betamethasone—psoriasis	0.000153	0.000584	CcSEcCtD
Argatroban—Vomiting—Dexamethasone—psoriasis	0.000153	0.000584	CcSEcCtD
Argatroban—Rash—Dexamethasone—psoriasis	0.000152	0.000579	CcSEcCtD
Argatroban—Rash—Betamethasone—psoriasis	0.000152	0.000579	CcSEcCtD
Argatroban—Dermatitis—Betamethasone—psoriasis	0.000152	0.000578	CcSEcCtD
Argatroban—Dermatitis—Dexamethasone—psoriasis	0.000152	0.000578	CcSEcCtD
Argatroban—Gastrointestinal disorder—Methotrexate—psoriasis	0.000152	0.000577	CcSEcCtD
Argatroban—Headache—Dexamethasone—psoriasis	0.000151	0.000575	CcSEcCtD
Argatroban—Headache—Betamethasone—psoriasis	0.000151	0.000575	CcSEcCtD
Argatroban—Pain—Methotrexate—psoriasis	0.00015	0.000571	CcSEcCtD
Argatroban—Feeling abnormal—Methotrexate—psoriasis	0.000145	0.00055	CcSEcCtD
Argatroban—Diarrhoea—Prednisone—psoriasis	0.000144	0.000547	CcSEcCtD
Argatroban—Gastrointestinal pain—Methotrexate—psoriasis	0.000144	0.000546	CcSEcCtD
Argatroban—Nausea—Betamethasone—psoriasis	0.000143	0.000545	CcSEcCtD
Argatroban—Nausea—Dexamethasone—psoriasis	0.000143	0.000545	CcSEcCtD
Argatroban—Dizziness—Prednisone—psoriasis	0.000139	0.000529	CcSEcCtD
Argatroban—Abdominal pain—Methotrexate—psoriasis	0.000139	0.000528	CcSEcCtD
Argatroban—Body temperature increased—Methotrexate—psoriasis	0.000139	0.000528	CcSEcCtD
Argatroban—Vomiting—Prednisone—psoriasis	0.000134	0.000508	CcSEcCtD
Argatroban—Rash—Prednisone—psoriasis	0.000132	0.000504	CcSEcCtD
Argatroban—Dermatitis—Prednisone—psoriasis	0.000132	0.000503	CcSEcCtD
Argatroban—Headache—Prednisone—psoriasis	0.000132	0.000501	CcSEcCtD
Argatroban—Hypersensitivity—Methotrexate—psoriasis	0.000129	0.000492	CcSEcCtD
Argatroban—Nausea—Prednisone—psoriasis	0.000125	0.000475	CcSEcCtD
Argatroban—Diarrhoea—Methotrexate—psoriasis	0.00012	0.000457	CcSEcCtD
Argatroban—Dizziness—Methotrexate—psoriasis	0.000116	0.000442	CcSEcCtD
Argatroban—Vomiting—Methotrexate—psoriasis	0.000112	0.000425	CcSEcCtD
Argatroban—Rash—Methotrexate—psoriasis	0.000111	0.000421	CcSEcCtD
Argatroban—Dermatitis—Methotrexate—psoriasis	0.000111	0.000421	CcSEcCtD
Argatroban—Headache—Methotrexate—psoriasis	0.00011	0.000418	CcSEcCtD
Argatroban—Nausea—Methotrexate—psoriasis	0.000104	0.000397	CcSEcCtD
Argatroban—CYP3A4—Xenobiotics—CYP2S1—psoriasis	7.82e-05	0.0399	CbGpPWpGaD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	6.99e-05	0.0357	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—ICAM1—psoriasis	6.92e-05	0.0353	CbGpPWpGaD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	6.9e-05	0.0352	CbGpPWpGaD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	5.67e-05	0.0289	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—ITGAL—psoriasis	5.39e-05	0.0275	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—IFNG—psoriasis	5.27e-05	0.0269	CbGpPWpGaD
Argatroban—F2—Hemostasis—SERPINB8—psoriasis	5.03e-05	0.0257	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	4.47e-05	0.0228	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—NFKB1—psoriasis	4.38e-05	0.0224	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—CAT—psoriasis	4.22e-05	0.0215	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—CRP—psoriasis	4.12e-05	0.021	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—APOE—psoriasis	4.03e-05	0.0206	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL4—psoriasis	3.88e-05	0.0198	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—ICAM1—psoriasis	3.79e-05	0.0193	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CCL20—psoriasis	3.46e-05	0.0177	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—HCAR2—psoriasis	3.41e-05	0.0174	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—CAT—psoriasis	3.35e-05	0.0171	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—CRP—psoriasis	3.35e-05	0.0171	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	3.25e-05	0.0166	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	3.21e-05	0.0164	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—ICAM1—psoriasis	3.08e-05	0.0157	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP2S1—psoriasis	3.01e-05	0.0154	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	2.97e-05	0.0151	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—IFNG—psoriasis	2.88e-05	0.0147	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—CRP—psoriasis	2.66e-05	0.0136	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	2.63e-05	0.0134	CbGpPWpGaD
Argatroban—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	2.6e-05	0.0133	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—ICAM1—psoriasis	2.45e-05	0.0125	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	2.44e-05	0.0124	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—NFKB1—psoriasis	2.4e-05	0.0122	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IFNG—psoriasis	2.34e-05	0.012	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	2.32e-05	0.0119	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—NFKB1—psoriasis	1.95e-05	0.00995	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—HCAR2—psoriasis	1.93e-05	0.00982	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriasis	1.89e-05	0.00967	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—TNF—psoriasis	1.87e-05	0.00952	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IFNG—psoriasis	1.86e-05	0.0095	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCL20—psoriasis	1.77e-05	0.00903	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HCAR2—psoriasis	1.75e-05	0.00892	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—NFKB1—psoriasis	1.55e-05	0.00791	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TNF—psoriasis	1.52e-05	0.00774	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—IL6—psoriasis	1.51e-05	0.00768	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.49e-05	0.00761	CbGpPWpGaD
Argatroban—F2—Hemostasis—ITGAL—psoriasis	1.46e-05	0.00745	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP2S1—psoriasis	1.4e-05	0.00714	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	1.38e-05	0.00704	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TP53—psoriasis	1.34e-05	0.00683	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—REN—psoriasis	1.3e-05	0.00666	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL6—psoriasis	1.22e-05	0.00625	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—CAT—psoriasis	1.21e-05	0.00616	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—TNF—psoriasis	1.21e-05	0.00615	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.04e-05	0.00531	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HCAR2—psoriasis	1.03e-05	0.00527	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCL20—psoriasis	1e-05	0.0051	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	9.73e-06	0.00497	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IL6—psoriasis	9.73e-06	0.00496	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CXCL8—psoriasis	9.36e-06	0.00477	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL20—psoriasis	9.08e-06	0.00463	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TAGAP—psoriasis	8.96e-06	0.00457	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—ACE—psoriasis	8.14e-06	0.00416	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—psoriasis	6.73e-06	0.00344	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	6.28e-06	0.0032	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NDUFA5—psoriasis	6.05e-06	0.00309	CbGpPWpGaD
Argatroban—F2—Hemostasis—NOS2—psoriasis	5.99e-06	0.00306	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL20—psoriasis	5.36e-06	0.00274	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2S1—psoriasis	5.15e-06	0.00263	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—LEP—psoriasis	5.06e-06	0.00258	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCL8—psoriasis	4.78e-06	0.00244	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	4.76e-06	0.00243	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—psoriasis	3.47e-06	0.00177	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CXCL8—psoriasis	3.36e-06	0.00172	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SOCS1—psoriasis	2.95e-06	0.00151	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—TYK2—psoriasis	2.82e-06	0.00144	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NDUFA5—psoriasis	2.81e-06	0.00144	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL8—psoriasis	2.7e-06	0.00138	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—psoriasis	2.62e-06	0.00134	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CARM1—psoriasis	2.51e-06	0.00128	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL8—psoriasis	2.45e-06	0.00125	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2S1—psoriasis	2.39e-06	0.00122	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOE—psoriasis	2.18e-06	0.00111	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LEP—psoriasis	2.18e-06	0.00111	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NFKBIA—psoriasis	2.03e-06	0.00104	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TYK2—psoriasis	1.66e-06	0.000849	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CAT—psoriasis	1.55e-06	0.000789	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL8—psoriasis	1.45e-06	0.000739	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—psoriasis	1.38e-06	0.000703	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JUN—psoriasis	1.35e-06	0.000687	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NFKB1—psoriasis	1.3e-06	0.000661	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOE—psoriasis	1.2e-06	0.000613	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—psoriasis	1.18e-06	0.0006	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CARM1—psoriasis	1.17e-06	0.000596	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT3—psoriasis	1.17e-06	0.000594	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARG—psoriasis	1.05e-06	0.000534	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—psoriasis	8.89e-07	0.000454	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—psoriasis	8.14e-07	0.000415	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CAT—psoriasis	7.19e-07	0.000367	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOE—psoriasis	5.58e-07	0.000285	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARG—psoriasis	4.86e-07	0.000248	CbGpPWpGaD
